H3K79 histone methyl transferase DOT1L inhibitor Compound 55 effect on breast cancer cells: dose response - - GEO DataSets

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

H3K79 histone methyl transferase DOT1L inhibitor Compound 55 effect on breast cancer cells: dose response

Analysis of MDA-MB-231 breast cancer cells treated with DOT1L (disruptor of telomeric silencing 1 like) inhibitor Compound 55 or DOT1L siRNA. DOT1L is a histone H3-lysine79 (H3K79) methyltransferase. Results provide insight into the role of DOT1L/H3K79 methylation in breast cancer.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 3 agent, 4 dose sets

Platform:: GPL10558
Series:: GSE56630
8 Samples

Download data

DataSet

Accession:: GDS5620

ID:: 5620

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Your browsing activity is temporarily unavailable.

GEO DataSets

Functional Genomics Studies

Result Filters